1. Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells: restoring the phenotype and drug sensitivity and reducing ATF4 mediated stress response. (July 2016) Authors: Bulle, A.; Dekervel, J.; Windmolders, P.; Lambrechts, L.; Van Cutsem, E.; Verslype, C.; Van Pelt, J. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD. Issue 5 (8th January 2016) Authors: Fevery, J.; Van Steenbergen, W.; Van Pelt, J.; Laleman, W.; Hoffman, I.; Geboes, K.; Vermeire, S.; Nevens, F. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 5(2016) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validation of a model of drug-induced aggressive liver cancer: gene expression and tumor recurrence. (July 2016) Authors: Van Pelt, J.; Dekervel, J.; Bulle, A.; Van Malenstein, H.; Windmolders, P.; Van Cutsem, E.; Verslype, C. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗